Platinum Priority – EditorialReferring to the article published on pp. 183–192 of this issueDisrupting the Status Quo in Prostate Cancer Diagnosis
Referring to the article published on pp. 183–192 of this issue
Section snippets
Conflicts of interest
The authors have nothing to disclose
References (10)
- et al.
Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators
Eur Urol
(2017) - et al.
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes
Eur Urol
(2015) - et al.
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study
EBioMedicine
(2015) - et al.
Integrative genomic profiling of human prostate cancer
Cancer Cell
(2010) - et al.
The genetic classification of prostate cancer: what's on the horizon?
Future Oncol
(2016)
There are more references available in the full text version of this article.
Cited by (0)
Crown Copyright © 2016 Published by Elsevier B.V. on behalf of European Association of Urology. All rights reserved.